Clinical Trial Update: A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating BL0020 in combination with toripalimab for recurrent extensive-stage small cell lung cancer; the study status is NOT_YET_REC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• BL0020
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Best-Link Bioscience, LLC | Conditions: Small Cell Carcinoma of Lung | Phase 1 | Status: NOT_YET_RECRUITING